Takimoto GS, Tung L, Abdel-Hafiz H, Abel MG, Sartorius CA, Richer JK, Jacobsen BM, Bain DL and Horwitz KB. Functional properties of the N-terminal region of progesterone receptors and their mechanistic relationship to structure. J STER BIOCH & MOL BIOL, 85: 209-219, 2003.
Jacobsen BM, Richer JK, Sartorius CA and Horwitz KB. Expression profiling of human breast cancers and gene regulation by progesterone receptors. J OF MAMMARY GLAND BIOLOGY & NEOPLASIA, 8:257:268, 2003.
Hopp TA, Weiss HL, Hilsenbeck SG, Cui Y, Allred DC, Horwitz KB and Fuqua SAW. Breast cancer patients with Progesterone Receptor-A rich tumors have poorer disease-free survival. CLINICAL CANCER RESEARCH, 10:2751-2760, 2004.
Jacobsen BM, Richer JK, Schittone S and Horwitz KB. Progesterone independent effects of progesterone receptors (PR) in estrogen receptor positive breast cancer: PR isoform-specific gene regulation and tumor biology. MOLECULAR ENDOCRINOLOGY, 19(3): 574-587, 2005.
Fuqua SAW, Cui Y, Lee AV, Osborne CK and Horwitz KB. Response to: "Time to Stop Progesterone Receptor Testing in Breast Cancer Management. Olivoto et al. JCO 22(2004):1769". JOURNAL OF CLINICAL ONCOLOGY, 23(4): 931-932, 2005.
Chadli A, Graham JD, Abel MG, Jackson TA, Gordon DF, Wood WM, Felts SJ, Horwitz KB and Toft DO. GC UNC-45 is a novel co-chaperone for the progesterone receptor/hsp 90 pathway. EMBO J, in press, 2005.
Ghatge R, Jacobsen BM, Schittone S, Horwitz KB. Medroxyprogesterone acetate in breast cancer cells: Gene regulatory overlap with dihydrotestosterone in breast cancer cells. ENDOCRINOLOGY, in press 2005.
Sartorius CA, Harvell DME, Shen T and Horwitz KB. Progestins initiate a luminal to myoepithelial switch in estrogen dependent human breast tumors without altering growth. CANCER RESEARCH, in press 2005.
Harvell DME, Sartorius CA, Richer JK, Allred DC and Horwitz KB. Estrogens regulate different genes in human breast tumor xenorafts compared to the identical cells in culture. Submitted, 2005.
Latest Publications in PubMed